Encompass Health Corp (EHC)

126.28 0 (0%)

As of 2025-10-28 15:23:49 EST

Encompass Health Corporation, based in Birmingham, Alabama, is the nation's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 166 inpatient rehabilitation hospitals located in 38 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.

Traded asNYSE: EHC
ISINUS29261A1007
CIK0000785161
LEI549300FVRPM9DRQZRG64
EIN630860407
SectorHealthcare
IndustryServices-Hospitals
CEOMark Tarr
Employees40,200
Fiscal Year End1231
Address9001 LIBERTY PARKWAY, BIRMINGHAM, AL, 35242
Phone205-967-7116
Websitehttp://encompasshealth.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
EHCEncompass Health Corp2025-10-28 15:23:49126.2800
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
EHC0000785161Encompass Health CorpUS29261A1007549300FVRPM9DRQZRG64630860407NYSE8060Services-Hospitals1231DE9001 LIBERTY PARKWAYBIRMINGHAMAL35242UNITED STATESUS205-967-71169001 LIBERTY PARKWAY, BIRMINGHAM, AL, 352429001 LIBERTY PARKWAY, BIRMINGHAM, AL, 35242HEALTHSOUTH CORPHealthcare1984Mark Tarr40,200http://encompasshealth.com8,500,000,000116,036,500100,723,828Encompass Health Corporation, based in Birmingham, Alabama, is the nation's largest provider of inpatient rehabilitative services, offering facility-based care through its network of 166 inpatient rehabilitation hospitals located in 38 states and Puerto Rico. Encompass Health's hospitals focus on providing rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The company operated a home health and hospice business that was spun off as Enhabit in 2022.2025-10-23 12:47:05
This is a preview of the latest data. Subscribe to access the full data.
EHC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
EHC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20248,500,000,0001,800,000,00026.8657100,709,106569,0750.5683
20236,700,000,0001,200,000,00021.8182100,140,031412,6090.4137
20225,500,000,000-2,100,000,000-27.631699,727,422289,2070.2908
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Patrick DarbySecretary, Executive Vice President, General Counsel2024625,0000923,376792,79711,5002,558,994
Elissa J. CharbonneauChief Medical Officer2024415,0000501,762350,94523,8801,291,587
Mark J. TarrChief Executive Officer, President20241,050,00004,856,9822,131,038178,6219,301,929
Douglas E. ColtharpChief Financial Officer, Executive Vice President2024700,00001,723,5161,006,32453,7763,868,736
Andrew L. PriceChief Accounting Officer2024345,0000417,186291,74919,5771,073,512
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202440,000
202338,000
202235,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue5,373,200,0004,801,200,0004,348,600,000
Cost Of Revenue———
Gross Profit———
Research And Development Expenses———
General And Administrative Expenses209,200,000201,700,000154,300,000
Operating Expenses4,508,700,0004,069,400,0003,718,400,000
Operating Income——539,500,000
Net Income455,700,000352,000,000271,000,000
Earnings Per Share Basic4.533.512.72
Earnings Per Share Diluted4.463.472.7
Weighted Average Shares Outstanding Basic99,900,00099,500,00099,200,000
Weighted Average Shares Outstanding Diluted102,200,000101,300,000100,400,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents85,400,00069,100,00021,800,000
Marketable Securities Current———
Accounts Receivable598,800,000611,600,000536,800,000
Inventories———
Non Trade Receivables———
Other Assets Current122,700,00091,500,0006,700,000
Total Assets Current886,900,000841,800,000717,200,000
Marketable Securities Non Current———
Property Plant And Equipment———
Other Assets Non Current219,200,000191,600,000222,000,000
Total Assets Non Current5,647,800,0005,260,600,0004,919,300,000
Total Assets6,534,700,0006,102,400,0005,636,500,000
Accounts Payable171,000,000170,000,000132,900,000
Deferred Revenue———
Short Term Debt138,600,00024,800,00025,200,000
Other Liabilities Current238,600,000187,400,000181,000,000
Total Liabilities Current841,000,000656,400,000575,900,000
Long Term Debt2,359,200,0002,687,800,0002,741,800,000
Other Liabilities Non Current51,800,00046,100,00045,300,000
Total Liabilities Non Current2,844,500,0003,148,800,0003,198,700,000
Total Liabilities3,685,500,0003,805,200,0003,774,600,000
Common Stock1,200,0001,200,0001,100,000
Retained Earnings796,700,000406,500,000115,700,000
Accumulated Other Comprehensive Income———
Total Shareholders Equity2,067,000,0001,647,500,0001,310,300,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization299,600,000273,900,000243,600,000
Share Based Compensation Expense48,300,00050,600,00029,200,000
Other Non Cash Income Expense-14,700,000-5,200,000-20,300,000
Change In Accounts Receivable-3,000,00022,400,00016,900,000
Change In Inventories———
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable3,000,00011,800,0002,300,000
Change In Other Liabilities52,800,00015,600,0009,100,000
Cash From Operating Activities1,002,800,000850,800,000705,800,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities——0
Acquisition Of Property Plant And Equipment642,500,000583,100,000564,800,000
Acquisition Of Business—00
Other Investing Activities7,200,000-3,300,0004,200,000
Cash From Investing Activities-653,300,000-602,800,000-627,000,000
Tax Withholding For Share Based Compensation12,100,0008,200,0007,300,000
Payments Of Dividends65,100,00060,700,00086,300,000
Issuance Of Common Stock———
Repurchase Of Common Stock31,100,000—0
Issuance Of Long Term Debt80,000,00060,000,000240,000,000
Repayment Of Long Term Debt———
Other Financing Activities2,100,0001,200,000300,000
Cash From Financing Activities-330,600,000-197,200,000-145,700,000
Change In Cash18,900,00050,800,000-66,900,000
Cash At End Of Period85,400,00069,100,00021,800,000
Income Taxes Paid164,500,000109,300,00051,200,000
Interest Paid146,800,000147,700,000178,400,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share4.533.512.72
Price To Earnings Ratio20.386319.008521.989
Earnings Growth Rate29.059829.0441-34.4578
Price Earnings To Growth Ratio0.70150.6545-0.6381
Book Value Per Share28.520523.087418.7692
Price To Book Ratio3.2382.88993.1866
Ebitda1,057,200,000878,700,000741,500,000
Enterprise Value11,638,165,0009,282,140,0008,678,352,000
Dividend Yield0.00710.00910.0145
Dividend Payout Ratio0.14290.17240.3185
Debt To Equity Ratio1.20841.64652.1117
Capital Expenditures———
Free Cash Flow———
Return On Equity0.22050.21370.2068
One Year Beta0.51870.49750.7642
Three Year Beta0.6670.6730.8601
Five Year Beta0.80710.83080.8374
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Williams TerranceDirector2025-10-1523A15,141
SCHLICHTING NANCY MDirector2025-10-1533A21,219
Reidy Christopher RDirector2025-10-1516A14,797
Reidy Christopher RDirector2025-10-15288A15,085
O'Connor Kevin J.Director2025-10-1514A9,895
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Lisa McClain2025-08-13MI09Purchase2025-07-22Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
QRG CAPITAL MANAGEMENT, INC.2025-09-301,022,0968,047127.0158
EVERGREEN CAPITAL MANAGEMENT LLC2025-09-30451,3033,553127.0203
MeadowBrook Investment Advisors LLC2025-09-3077,609611127.0196
Arlington Trust Co LLC2025-09-3085,230671127.0194
REINHART PARTNERS, LLC.2025-09-3046,053,343362,551127.0258
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Meeder Funds2025-09-30Adviser ClassSRUAX3,775479,500.50.1958
Meeder Funds2025-09-30Institutional ClassSRUIX3,775479,500.50.1958
Meeder Funds2025-09-30Retail ClassFLSPX3,775479,500.50.1958
Meeder Funds2025-09-30Institutional ClassFLMIX14,6671,863,002.340.1733
Meeder Funds2025-09-30Adviser ClassFLMAX14,6671,863,002.340.1733
This is a preview of the latest data. Subscribe to access the full data.